The Use of the Propeller Health Platform to Improve Inhaled Corticosteroid (ICS) Use Among Adults With Uncontrolled Persistent Asthma
NCT ID: NCT03860519
Last Updated: 2020-04-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
100 participants
INTERVENTIONAL
2018-03-07
2019-08-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Breathing Counts: Evaluating Adherence in the Presence of Asthma Navigation Support
NCT03065205
Asthma Digital Study
NCT04609644
Assessing the Use of Mobile Technology in Adult Asthma Patients
NCT03103880
Effect of the Use of an add-on Device Connected to a Smartphone App on Difficult-to-treat Asthmatic Patient's Adherence
NCT03951714
Feasibility and Acceptability of the Propeller Monitoring System in Children With Persistent Asthma
NCT03648450
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention Group
The components of the intervention unique to the treatment group include: 1) access to the Propeller Health Asthma App on his/her phone, which includes tracking of ICS and SABA usage; 2) receipt of NorthShore Connect physician alerts (these will be sent by the asthma nurse on behalf of the NS physician) if he/she has "poor adherence" ie missed 4 consecutive days of all of his/her controller medication dosages and their sensor has sent heartbeat to application OR "at risk" alerts if a patient transitions to a "not well controlled" or "poorly controlled" status (defined by the NHLBI guidelines); and 3) monthly phone calls with a nurse from his/her asthma doctor's office to review ICS and SABA usage reports (provided by Propeller Health on their Propeller Health dashboard).
Electronic Medication Monitors on ICS and SABA - Active Mode
The patients in the intervention group will have sensors that are "active", so that these patients receive reminders about when to use their inhalers medications.
Asthma App Tracking of ICS/SABA Usage - Active Mode
Patients in the intervention group will have access to their medication usage information (as collected by their sensors) via their Propeller Health applications.
NorthShore Connect Real Time ICS and SABA Usage Feedback - Yes
Patients in the intervention will receive feedback from the Research Nurse about their medication use and asthma control status.
Asthma Nurse Monthly Phone Calls for ICS/SABA Usage Feedback - Yes
Patients in the intervention group will receive monthly calls from the Research Nurse to obtain feedback information about the Propeller Health Platform.
Control Group
The control group will not receive access to view the contents of the Propeller Health Asthma App on his/her phone, NorthShore Connect alerts for missing ICS or overuse of SABA, or for his/her asthma doctor (the asthma nurse will be viewing this information on behalf of the asthma doctor) to view his/her ICS and SABA use on the Propeller Health dashboard until after the 3-month study has been completed.
Electronic Medication Monitors on ICS and SABA - Silent Mode
The patients in the control group will have sensors that are "silent", so that these patients do not receive reminders about when to use their inhalers medications.
Asthma App Tracking of ICS/SABA Usage - Silent Mode
Patients in the control group will not have access to their medication usage information (as collected by their sensors) via their Propeller Health applications.
NorthShore Connect Real Time ICS and SABA Usage Feedback - No
Patients in the intervention will not receive feedback from the Research Nurse about their medication use and asthma control status.
Asthma Nurse Monthly Phone Calls for ICS/SABA Usage Feedback - No
Patients in the control group will not receive monthly calls from the Research Nurse to obtain feedback information about the Propeller Health Platform.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Electronic Medication Monitors on ICS and SABA - Active Mode
The patients in the intervention group will have sensors that are "active", so that these patients receive reminders about when to use their inhalers medications.
Electronic Medication Monitors on ICS and SABA - Silent Mode
The patients in the control group will have sensors that are "silent", so that these patients do not receive reminders about when to use their inhalers medications.
Asthma App Tracking of ICS/SABA Usage - Active Mode
Patients in the intervention group will have access to their medication usage information (as collected by their sensors) via their Propeller Health applications.
Asthma App Tracking of ICS/SABA Usage - Silent Mode
Patients in the control group will not have access to their medication usage information (as collected by their sensors) via their Propeller Health applications.
NorthShore Connect Real Time ICS and SABA Usage Feedback - Yes
Patients in the intervention will receive feedback from the Research Nurse about their medication use and asthma control status.
NorthShore Connect Real Time ICS and SABA Usage Feedback - No
Patients in the intervention will not receive feedback from the Research Nurse about their medication use and asthma control status.
Asthma Nurse Monthly Phone Calls for ICS/SABA Usage Feedback - Yes
Patients in the intervention group will receive monthly calls from the Research Nurse to obtain feedback information about the Propeller Health Platform.
Asthma Nurse Monthly Phone Calls for ICS/SABA Usage Feedback - No
Patients in the control group will not receive monthly calls from the Research Nurse to obtain feedback information about the Propeller Health Platform.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Have an active NorthShore Connect (patient portal) account
* Persistent uncontrolled asthma in the past 12 months
* Active prescription for daily ICS medication for asthma
Exclusion Criteria
* the presence of other co-morbidities (e.g. severe psychiatric disorder) that could interfere with study participation
25 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Endeavor Health
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Giselle Mosnaim
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Giselle Mosnaim, MD
Role: PRINCIPAL_INVESTIGATOR
Endeavor Health
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
NorthShore University HealthSystem
Evanston, Illinois, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Mosnaim GS, Stempel DA, Gonzalez C, Adams B, BenIsrael-Olive N, Gondalia R, Kaye L, Shalowitz M, Szefler S. Electronic medication monitoring versus self-reported use of inhaled corticosteroids and short-acting beta2-agonists in uncontrolled asthma. J Asthma. 2022 Oct;59(10):2024-2027. doi: 10.1080/02770903.2021.1996600. Epub 2021 Nov 2.
Related Links
Access external resources that provide additional context or updates about the study.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EH17-322
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.